Adagio Therapeutics Inc. (NASDAQ: ADGI) Up 64.37% YTD: Could Trouble Be Ahead? – Marketing Sentinel
Home  »  Business   »  Adagio Therapeutics Inc. (NASDAQ: ADGI) Up 64.37% ...

Adagio Therapeutics Inc. (NASDAQ: ADGI) Up 64.37% YTD: Could Trouble Be Ahead?

Adagio Therapeutics Inc. (NASDAQ:ADGI)’s traded shares stood at 0.38 million during the last session. At the close of trading, the stock’s price was $34.32, to imply an increase of 9.30% or $2.92 in intraday trading. The ADGI share’s 52-week high remains $59.50, putting it -73.37% down since that peak but still an impressive 40.27% since price per share fell to its 52-week low of $20.50. The company has a valuation of $5.76B, with an average of 0.98 million shares in intraday trading volume over the past 10 days and average of 776.63K shares over the past 3 months.

Analysts have given a consensus recommendation of an Overweight for Adagio Therapeutics Inc. (ADGI), translating to a mean rating of 1.50. Of 4 analyst(s) looking at the stock, 0 analyst(s) give ADGI a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 3 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored

Adagio Therapeutics Inc. (NASDAQ:ADGI) trade information

After registering a 9.30% upside in the last session, Adagio Therapeutics Inc. (ADGI) has traded red over the past five days. The stock hit a weekly high of 36.00 this Friday, 10/08/21, jumping 9.30% in its intraday price action. The 5-day price performance for the stock is 22.66%, and -26.84% over 30 days. With these gigs, the year-to-date price performance is 64.37%.

Analysts on Wall Street suggest a consensus price target of $51.50, implying an increase of 33.36% to the stock’s current value. The extremes give us $33.00 and $60.00 for target low and target high price respectively. As such, ADGI has been trading -74.83% off suggested target high and 3.85% from its likely low.

Adagio Therapeutics Inc. (ADGI) estimates and forecasts

ADGI Dividends

Adagio Therapeutics Inc. has its next earnings report out in November. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Adagio Therapeutics Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.

>> 7 Top Picks for the Post-Pandemic Economy <<

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam